Sofiva Genomics Co., Ltd. engages in the provision of pre-pregnancy, prenatal, and newborn genetic testing and medical testing services. It specializes in reproductive medicine testing, cancer, pregnant women testing, neonatal testing, rare diseases, and personalized genetic testing. The company was founded by I Ning Su on June 15, 2012 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company